Literature DB >> 12176771

Cisplatin contamination observed on the outside of drug vials.

Olle Nygren1, Bengt Gustavsson, Lena Ström, Arne Friberg.   

Abstract

Exposure to cytotoxic drugs is of great concern today. Special regulations for handling these drugs during preparation and administration have been implemented in most countries. Concern has also been raised as to whether exposure to these drugs can occur due to contaminated drug vials. In this investigation, wipe samples were taken from drug vials used for platinum-containing drugs, e.g. cisplatin and related drugs. The vials were randomly picked from unbroken packages from different manufacturers. The results showed that drug vials may already be contaminated on the outside when delivered from the manufacturer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176771     DOI: 10.1093/annhyg/mef074

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  6 in total

1.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

Review 2.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

3.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

4. 

Authors:  Annaelle Soubieux; Caroline Plante; Johann-François Ouellette-Frève; Audrey Chouinard; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2020-02-01

5.  Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry.

Authors:  E E M Brouwers; A D R Huitema; E N Bakker; J W Douma; K J M Schimmel; G van Weringh; P J de Wolf; J H M Schellens; J H Beijnen
Journal:  Int Arch Occup Environ Health       Date:  2007-03-22       Impact factor: 3.015

6.  Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC).

Authors:  Antoine F Villa; Souleiman El Balkhi; Radia Aboura; Herve Sageot; Helene Hasni-Pichard; Marc Pocard; Dominique Elias; Nathalie Joly; Didier Payen; François Blot; Joel Poupon; Robert Garnier
Journal:  Ind Health       Date:  2014-10-17       Impact factor: 2.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.